4//SEC Filing
Murray Dallan 4
Accession 0000950170-25-032762
CIK 0000873303other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:00 PM ET
Size
5.1 KB
Accession
0000950170-25-032762
Insider Transaction Report
Form 4
Murray Dallan
Chief Customer Officer
Transactions
- Tax Payment
Common Stock
2025-03-03$103.77/sh−711$73,780→ 21,506 total
Footnotes (2)
- [F1]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.
- [F2]Amount of Securities Beneficially Owned includes 194 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0002022303
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:00 PM ET
- Size
- 5.1 KB